risperidone has been researched along with Dilatation, Pathologic in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Dilatation, Pathologic: The condition of an anatomical structure's being dilated beyond normal dimensions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilms, G | 1 |
| Van Ongeval, C | 1 |
| Baert, AL | 1 |
| Claus, A | 1 |
| Bollen, J | 1 |
| De Cuyper, H | 1 |
| Eneman, M | 1 |
| Malfroid, M | 1 |
| Peuskens, J | 1 |
| Heylen, S | 1 |
1 trial available for risperidone and Dilatation, Pathologic
| Article | Year |
|---|---|
Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients.
Topics: Adult; Aged; Antipsychotic Agents; Brain; Cerebral Ventricles; Chronic Disease; Dilatation, Patholog | 1992 |